Historical record - last NADAC effective date: 5/19/2021
Product Information
DEXMETHYLPHENIDATE ER 30 MG CP is a generic product labeled by Amneal Pharmaceuticals of New York LLC, priced at $2.1547 per EA under NDC 00115168601. Its NADAC has been published 229 times since Jan 11, 2017.
FDA first approved this application on Nov 21, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
30 mg/1
Manufacturer
Amneal Pharmaceuticals of New York LLCNDC
00115168601
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
5/19/2021
Active Ingredients
DEXMETHYLPHENIDATE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA079108FDA Approved
11/21/2013
TE Code
AB
On Market Since
2/24/2014
Pharmacological Classes
Price Statistics
The NADAC for DEXMETHYLPHENIDATE ER 30 MG CP has been published 229 times since Jan 11, 2017, and over the history we have for it it has declined 57.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.1547 per EA |
|---|---|
| All-time high | $5.0693 (Jan 11, 2017) |
| All-time low | $1.8293 (Mar 17, 2021) |
| Median price | $4.0657 |
| Average price | $3.8297 |
| Largest weekly change | -61.8% (Feb 17, 2021) |
| Weeks tracked | 229 |
| Tracking since | Jan 11, 2017 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-57.5%
Last surveyed May 26, 2021 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 18% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DEXMETHYLPHENIDATE ER 30 MG CP?
The current National Average Drug Acquisition Cost (NADAC) for DEXMETHYLPHENIDATE ER 30 MG CP, manufactured by Amneal Pharmaceuticals of New York LLC, is $2.1547 per EA (NDC 00115168601), effective May 26, 2021.
How has the price of DEXMETHYLPHENIDATE ER 30 MG CP changed over time?
Over the history we have for it, the NADAC for DEXMETHYLPHENIDATE ER 30 MG CP has declined 57.5%. It has been tracked across 229 weekly CMS publications since Jan 11, 2017.
What are the highest and lowest recorded NADAC prices for DEXMETHYLPHENIDATE ER 30 MG CP?
Since Jan 11, 2017, the NADAC for DEXMETHYLPHENIDATE ER 30 MG CP has ranged from a low of $1.8293 (Mar 17, 2021) to a high of $5.0693 (Jan 11, 2017), with a median of $4.0657 per EA.
Are there cheaper alternatives to DEXMETHYLPHENIDATE ER 30 MG CP?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DEXMETHYLPHENIDATE ER 30 MG CP, is $1.7632 per EA — about 18% below DEXMETHYLPHENIDATE ER 30 MG CP.
Who manufactures DEXMETHYLPHENIDATE ER 30 MG CP?
DEXMETHYLPHENIDATE ER 30 MG CP (NDC 00115168601) is labeled by Amneal Pharmaceuticals of New York LLC, and CMS classifies it as a generic product.